This includes not only medications but also nutrition coaching, exercise, blood sugar monitoring, behavioral support, and, in some cases, surgery
Written by: Cheryl Reifsnyder, PhD and Janna Manjelievskaia, Director of Health Economics and Outcomes Research, Veradigm Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have established efficacy in glycemic control and weight loss in adult populations
It will be quite negative for our patients because data shows people typically regain weight after stopping the drugs, said Diana Thiara, medical director of the UCSF Weight Management Program
Compared to full-length growth hormone or GHRH analogs like tesamorelin, AOD-9604 provides more selective fat metabolism benefits without affecting the GH/IGF-1 axis or glucose regulation